광주광역시 요양시설 코로나19 집단 발생 사례에서 코로나19 백신 접종에 의한 사망 예방 효과
Effect of COVID-19 vaccinations on deaths of the COVID-19 cases in some elderly long-term care facilities, Gwangju
1
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Objectives: The purpose of this study was to identify the effectiveness of COVID-19 vaccinations on deaths of the COVID-19 cases in some elderly long-term care facilities (LTCF) in Gwangju Metropolitan City. Methods: The study subjects were 659 COVID-19 cases in residents of 7 elderly LTCF, Gwangju, from 21 Dec. 2021 to 28 Jan. 2022. The used variables were confirmed dates for COVID-19, demographic characteristics, co-morbidities, presentation of symptoms, death and vaccination related characteristics including type of vaccine, doses and dates. Vaccination status were classified as not vaccinated, partially and fully vaccinated. The associations of vaccination status and deaths of COVID-19 cases were tested by chi-square test and multiple logistic regression analysis. Results: The rates of not vaccinated, partially vaccinated and fully vaccinated were 19.4%, 10.2% and 70.4%, respectively. The mortality rate of the cases was 6.4%. The death rate by vaccination status was 16.4% in not vaccinated, 15.4% in partially vaccinated and 2.6% in fully vaccinated, showing a statistically significant difference. The adjusted odds ratios (ORs) (95% confidence intervals, CIs) of death compared to fully vaccinated were 7.64 (3.87-16.34) in non-vaccinated, and 6.97 (3.44-14.14) in partially vaccinated. Conclusions: COVID-19 vaccination seems to work effectively in preventing deaths of COVID-19 cases of elderly LTCF residents. This finding support that fully vaccinations in high risk group such as elderly LTCF residents is very important for one of strategies of COVID-19 management.
Abstract
Objectives: The purpose of this study was to identify the effectiveness of COVID-19 vaccinations on deaths of the COVID-19 cases in some elderly long-term care facilities (LTCF) in Gwangju Metropolitan City. Methods: The study subjects were 659 COVID-19 cases in residents of 7 elderly LTCF, Gwangju, from 21 Dec. 2021 to 28 Jan. 2022. The used variables were confirmed dates for COVID-19, demographic characteristics, co-morbidities, presentation of symptoms, death and vaccination related characteristics including type of vaccine, doses and dates. Vaccination status were classified as not vaccinated, partially and fully vaccinated. The associations of vaccination status and deaths of COVID-19 cases were tested by chi-square test and multiple logistic regression analysis. Results: The rates of not vaccinated, partially vaccinated and fully vaccinated were 19.4%, 10.2% and 70.4%, respectively. The mortality rate of the cases was 6.4%. The death rate by vaccination status was 16.4% in not vaccinated, 15.4% in partially vaccinated and 2.6% in fully vaccinated, showing a statistically significant difference. The adjusted odds ratios (ORs) (95% confidence intervals, CIs) of death compared to fully vaccinated were 7.64 (3.87-16.34) in non-vaccinated, and 6.97 (3.44-14.14) in partially vaccinated. Conclusions: COVID-19 vaccination seems to work effectively in preventing deaths of COVID-19 cases of elderly LTCF residents. This finding support that fully vaccinations in high risk group such as elderly LTCF residents is very important for one of strategies of COVID-19 management.
참고문헌 (29)
- "WHO Director-General’s opening remarks at the media briefing on COVID-19" (2020)[URL]
- "WHO COVID-19Dashboard. Situation by Region, Country, Territory and Area" (2022)[URL]
- "Coronavirus Disease 2019 (COVID-19)Dashboard"[URL]
- "COVID-19 vaccines"[URL]
- 안상현, "코로나19 예방접종의 최신지견과 임상적용", Korean Journal of Family Practice, 11(4), pp.236~246 (2021), 대한가정의학회[DOI]
- Polack EP, "Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine", N Engl J Med, 383(27), pp.2603~2315 (2020)[DOI]
- Rinott E, "Reduction in COVID-19 patients requiring mechanical ventilation following implementation of a National COVID-19 Vaccination Program-Israel, December 2020-February 2021", MMWR, 70(9), pp.326~328 (2021)
- Tenforde MW, "Association between mRNA vaccination and COVID-19 hospitalization and disease severity", JAMA, 326(20), pp.2043~2053 (2021)
- Thomas SJ, "Safety and Efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months", N Engl J Med, 385(19), pp.1761~1773 (2021)[DOI]
- Saban M, "Chanages in infectivity, severity and vaccine effectiveness against delta COVID-19 variant ten monthes into the vaccination program : The Israeli case", Prev Med, 154, pp.1~8 (2022)[DOI]
- Eyre DW, "Effect of Covid-19 vaccination on transmission of alpha and delta variants", N Engl J Med (2022)[DOI]
- Kim JA, "Effectiveness of COVID-19 vaccines in preventing severity and mortality, May to July, 2021", Public Health Weekly Report, 14(37), pp.2612~2615 (2021)
- "Tracking SARSCoV-2 variants"[URL]
- Ryu B, "Global trends and characteristics of the SARS-CoV-2 delta variant", Public Health Weekly Report, 14(33), pp.2354~2362 (2021)
- Woo I, "Updates of research trends for COVID-19 vaccine on SARS-CoV-2omicron variant", Public Health Weekly Report, 15(9), pp.556~563 (2022)
- Dejnirattisai W, "Reduced neutralization of SARS-CoV-2 omicron B. 1. 1. 529 variant by post-immunisation serum", Lancet, 399(10321), pp.234~236 (2022)[DOI]
- 김옥선, "국내 요양병원의 감염관리 현황과 감염관리 담당 간호사의 교육 요구도", 재활간호학회지, 21(1), pp.1~11 (2018), 한국재활간호학회
- McMichael TM, , N Eng l Med, 382(22), pp.2081~2090 (2020)[DOI]
- ECDC Public Health Emergency Team, "High impact of COVID-19 in long-term care facilities, suggestion for monitoring in the EU", EEA, May 2020, 2020, pp.25(22), 2000956~
- Jang J, "Coronavirus Disease-19(COVID-19)one-year outbreak major cluster infection report as of January 19, 2021, in the Republic of Korea", Public Health Weekly Report, 14(9), pp.482~495 (2021)
- Oh J, "Severity and case fatality rates according to Covid-19 vaccination history of Covid-19 confirmed inpatients of nursing hopitals in Gyeonggi province, Spetember-October, 2021", Public Health Weekly Report, 15(5), pp.305~312 (2022)
- Mazagatos C, "Effectiveness of mRNA COVID-19vaccines in preventing SARS-CoV-2infections and COVID-19 hospitalizations and deaths in elderly long-term care facility residents, Spain, weeks 53 2020 to 13 2021", Euro Surveill, 26(24), pp.2100452~ (2021)[DOI]
- Park H, "Comparisons of attack rates and case fatality rates for clusters of long-term care facilities infected with Delta versus Omicron COVID-19 variants", Public Health Weekly Report, 15(16), pp.1010~1017 (2022)
- Ferdinands JM, "Waning 2-dose and 3-dose effectiveness of mRNA vaccines against COVID-19 associated emergency department and urgent care encounters and hospitalizations among adults during periods of delta and omicron variant predominance – VISIONNetwork, 10 States, August 2021-January 2022", Morbid Mortal Wkly Rep, 71(7), pp.255~263 (2022)
- Accorsi EK, "Association between 3 doses of mRNA COVID-19vaccine and symptomatic infection caused by the SARS-CoV-2 Omicron and Delta variants", JAMA, 327(7), pp.639~651 (2022)
- Nemet I, "Third BNT162b2 vaccination neutralization of SARS-CoV-2 omicron infection", N Engl J Med, 386(5) (2022)[DOI]
- "2021 COVID-19in Gwangju FACT SHEET"[URL]
- "Coronavirus Disease 2019 (COVID-19)Dashboard" (2022)[URL]
- 김상헌, "한국 코로나바이러스감염증-19 환자의 특성과 경과; 국가 데이터베이스의 분석", Allergy Asthma & Respiratory Disease, 9(3), pp.113~114 (2021), 대한 소아알레르기 호흡기학회[DOI]
